Results 51 to 60 of about 1,676 (161)

Advances in understanding and managing bullous pemphigoid [version 1; referees: 2 approved]

F1000Research, 2015
Bullous pemphigoid (BP) is the commonest subtype of autoimmune blistering disease in most countries of the world. It occurs most frequently in elderly patients and is characterised clinically by large, tense blisters in the skin preceded by urticarial ...
Cathy Y. Zhao, Dedee F. Murrell
doaj   +1 more source

Immunotherapy‐Related Cutaneous Toxicities in Melanoma: A Dermoscopic Perspective

JEADV Clinical Practice, Volume 5, Issue 2, Page 402-414, June 2026.
Dermoscopy serves as a valuable tool in the everyday dermatological and oncological practice for melanoma patients, allowing for the prompt identification of immune‐related cutaneous toxicities and guiding clinicians toward appropriate therapeutic decisions.
Grażyna Kamińska‐Winciorek, Iris Zalaudek, Karolina Zarańska, Bożena Cybulska‐Stopa   +3 more
wiley   +1 more source

Mucosal Involvement in Bullous Pemphigoid Is Mostly Associated with Disease Severity and to Absence of Anti-BP230 Autoantibody

Frontiers in Immunology, 2018
Bullous pemphigoid (BP) is the most common autoimmune bullous disease and typically affects the elderly. Binding of specific autoantibodies to BP180/230 hemidesmosomal components induces an inflammatory response leading to skin blister formation. Unusual
Ariane Clapé, Ariane Clapé, Ariane Clapé, Céline Muller, Grégory Gatouillat, Grégory Gatouillat, Sébastien Le Jan, Coralie Barbe, Bach-Nga Pham, Bach-Nga Pham, Frank Antonicelli, Frank Antonicelli, Philippe Bernard, Philippe Bernard   +13 more
doaj   +1 more source

Ocular mucous membrane pemphigoid: A retrospective study

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Neda Cramer, Johannes Mohr, Rotraut Mössner, Christian van van Oterendorp   +3 more
wiley   +1 more source

Bullous Pemphigoid Severity and Levels of Antibodies to BP180 and BP230: A Systematic Review and Meta-Analysis.

JAMA Dermatol
ImportanceThe correlation between serum levels of autoantibodies against bullous pemphigoid (BP) antigens 180 (BP180) and 230 (BP230) with BP disease severity is unclear.ObjectiveTo investigate the correlation of anti-BP180 and anti-BP230 immunoglobulin G (IgG) antibody levels with BP disease severity.Data SourcesA search was performed of the Cochrane ...
Chou PY, Yu CL, Wen CN, Tu YK, Chi CC.
europepmc   +4 more sources

Post-Surgical Anti-BP230 Bullous Pemphigoid: A Rare Cause of Non-Healing Wound

Dermatology Practical & Conceptual
Description of a case of post-surgical bullous pemphigoid with anti-BP230 ...
Carlo Pipitò, Maria Efenesia Baffa, Roberto Maglie, Stefano Senatore, Emiliano Antiga   +4 more
doaj   +3 more sources

Managing Skin Side Effects Associated With Oncology Treatments: Asian Perspective on Use of Dermocosmetics

Asia-Pacific Journal of Clinical Oncology, Volume 22, Issue 2, Page 186-198, April 2026.
Skin adverse events (AEs) frequently accompany all types of anticancer treatments. This publication discusses how recent international guidance on best‐practices use of dermocosmetics can be adapted to the North Asia region (China, Hong Kong, Japan, Republic of Korea, and Taiwan).
Meng Pan, Jianguo Sun, Makoto Kawashima, You Chan Kim, Mison Chun, Chia‐Yu Chu, Yi‐Hsin Liang, Mee Chang, Delphine Kerob, Brigitte Dreno   +9 more
wiley   +1 more source

Adjuvant therapy of severe and/or refractory bullous pemphigoid with immunoadsorption – A prospective monocenter pilot study

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 4, Page 472-479, April 2026.
Summary Background and Objectives Bullous pemphigoid (BP) is the most common autoimmune blistering disease in the Western world. While remission is achieved in the majority of BP patients by long‐term use of corticosteroids with or without immunomodulants/immunosuppressants, national and international guidelines recommend adjuvant immunoadsorption (IA)
Maike M. Holtsche, Nina van Beek, Christoph M. Hammers, Artem Vorobyev, Michael Kasperkiewicz, Nina Schumacher, Philip Muck, Enno Schmidt   +7 more
wiley   +1 more source

Brein en blaren: een bijzondere band

Tijdschrift voor Gerontologie en Geriatrie
Bulleus pemphigoid (BP) is een dermatologische auto-immuun ziekte die zich kenmerkt door jeuk en blaren. Soms wordt jarenlang jeuk en een eczemateus huidbeeld gezien voorafgaand aan het ontstaan van blaren, waardoor BP niet altijd tijdig herkend wordt ...
Floor Lijten, Amée Wolters, Rianne Esselink, Satish Lubeek   +3 more
doaj   +1 more source

Profiling the serum cytokine B cell activating factor (BAFF),proliferation inducing ligand (APRIL), and BP180, BP230 antibodies in bullous pemphigoid patients before and after treatment: a prospective case-control study

Clinical Immunology Communications
Background: Bullous pemphigoid is a subepidermal autoimmune blistering disease caused by auto-antibodies directed against specific components of the basement membrane molecules.
Shadab Seraji, Kamran Balighi, Amir Hooshang Ehsani, Ala Ehsani, Hamidreza Mahmoudi, Maryam Daneshpazhooh, Pedram Noormohammadpour, Saman Al Zahawi, Zeinab Aryanian, Parvaneh Hatami   +9 more
doaj   +1 more source